ES2075081T3 - Derivados de carbonatos de eserolina, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

Derivados de carbonatos de eserolina, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2075081T3
ES2075081T3 ES90105562T ES90105562T ES2075081T3 ES 2075081 T3 ES2075081 T3 ES 2075081T3 ES 90105562 T ES90105562 T ES 90105562T ES 90105562 T ES90105562 T ES 90105562T ES 2075081 T3 ES2075081 T3 ES 2075081T3
Authority
ES
Spain
Prior art keywords
eseroline
medicines
carbonates
derivatives
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90105562T
Other languages
English (en)
Inventor
Edward J Glamkowski
Yulin Chiang
Barbara E Kurys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2075081T3 publication Critical patent/ES2075081T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL INVENTO RELATA ESTERES CARBONATOS 1,2,3,3A,8,8A-HEXAHIDRO-1,3A,8-TRIMETILPIRROLO[2,3-B]INDOL-5-OL DE LA FORMULA DONDE R ES ALQUIL REDUCIDO, CICLOALQUIL, ARIL, ARALQUIL O X ES HIDROGENO O HALOGENO; SUS SALES DE ADICCION DE ACIDO ACEPTABLES FARMACEUTICAMENTE Y DONDE APLICABLES A LOS ISOMEROS OPTICOS Y GEOMETRICOS Y SUS MEZCLAS RACEMICAS. LOS COMPONENTES DE ESTE INVENTO MUESTRAN UTILIDAD COMO AGENTES ANALGESICOS.
ES90105562T 1989-03-27 1990-03-23 Derivados de carbonatos de eserolina, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2075081T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/329,171 US4971992A (en) 1989-03-27 1989-03-27 Carbonate derivatives of eseroline

Publications (1)

Publication Number Publication Date
ES2075081T3 true ES2075081T3 (es) 1995-10-01

Family

ID=23284183

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90105562T Expired - Lifetime ES2075081T3 (es) 1989-03-27 1990-03-23 Derivados de carbonatos de eserolina, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (18)

Country Link
US (1) US4971992A (es)
EP (1) EP0389984B1 (es)
JP (1) JPH0737458B2 (es)
KR (1) KR0163049B1 (es)
AT (1) ATE124044T1 (es)
AU (1) AU621208B2 (es)
CA (1) CA2013087C (es)
DE (1) DE69020205T2 (es)
DK (1) DK0389984T3 (es)
ES (1) ES2075081T3 (es)
FI (1) FI92932C (es)
HU (1) HU204053B (es)
IE (1) IE67449B1 (es)
IL (1) IL93895A (es)
NO (1) NO173995C (es)
NZ (1) NZ233065A (es)
PT (1) PT93535B (es)
ZA (1) ZA902307B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US4983616A (en) * 1990-02-01 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
US5216017A (en) * 1990-05-11 1993-06-01 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo[2,3-b]indole-ketones and analogs
AU634654B2 (en) * 1990-05-11 1993-02-25 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
AU634380B2 (en) * 1990-05-17 1993-02-18 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo(2,3-b)indole acetic acids, esters, amides and related analogs, a process for their preparation and their use as medicaments
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
US5409948A (en) * 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
AT404907B (de) * 1993-07-13 1999-03-25 Andritz Patentverwaltung Verfahren und anlage zum herstellen von edelstahlband
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (en) * 2004-06-01 2005-12-01 Axonyx, Inc. Transdermal delivery system for treatment of cognitive disorders
US20050272804A1 (en) * 2004-06-08 2005-12-08 Axonyx, Inc Methods of delaying Alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and a HMG CoA reductase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine

Also Published As

Publication number Publication date
NO173995C (no) 1994-03-02
FI92932B (fi) 1994-10-14
IE901097L (en) 1990-09-27
KR900014388A (ko) 1990-10-23
FI92932C (fi) 1995-01-25
EP0389984A1 (en) 1990-10-03
EP0389984B1 (en) 1995-06-21
HUT54159A (en) 1991-01-28
US4971992A (en) 1990-11-20
DE69020205D1 (de) 1995-07-27
FI901470A0 (fi) 1990-03-23
NO901385L (no) 1990-09-28
AU621208B2 (en) 1992-03-05
ATE124044T1 (de) 1995-07-15
CA2013087C (en) 1999-12-28
JPH02289572A (ja) 1990-11-29
DE69020205T2 (de) 1995-12-07
DK0389984T3 (da) 1995-10-30
PT93535B (pt) 1996-03-29
AU5220290A (en) 1990-11-08
JPH0737458B2 (ja) 1995-04-26
IL93895A0 (en) 1990-12-23
NZ233065A (en) 1992-04-28
ZA902307B (en) 1990-12-28
IE67449B1 (en) 1996-04-03
PT93535A (pt) 1990-11-07
KR0163049B1 (ko) 1998-12-01
HU204053B (en) 1991-11-28
NO901385D0 (no) 1990-03-26
HU901832D0 (en) 1990-08-28
CA2013087A1 (en) 1990-09-27
NO173995B (no) 1993-11-22
IL93895A (en) 1995-07-31

Similar Documents

Publication Publication Date Title
ES2075081T3 (es) Derivados de carbonatos de eserolina, un procedimiento para su preparacion y su uso como medicamentos.
MX21088A (es) N-heteroanil-purin-6-aminas, y un proceso para su preparacion y su uso como medicamentos.
AU626740B2 (en) Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments
DK0571243T3 (da) Thiochromanderivater, fremgangsmåder til fremstilling heraf samt farmaceutiske midler indeholdende d isse

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 389984

Country of ref document: ES